Gadofosveset for Axillary Staging in Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Gadofosveset contrast agent enhanced MRI Axilla
Sponsor: Maastricht University Medical Center